ALRN - Aileron Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-6.71M

Cash

12.07M

Avg Qtr Burn

-3.457M

Short % of Float

0.15%

Insider Ownership

9.03%

Institutional Own.

23.19%

Qtr Updated

09/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ALRN-6924 Details Cancer, Breast cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALRN-6924 Details Cancer, Non-small cell lung carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.